Avendus completed the acquisition of a stake in Indegene from Carlyle and Brighton Park.

Avendus, a private equity growth expansion fund, completed the acquisition of a stake in Indegene, a company offering research and development and management services to healthcare and pharmaceutical enterprises, from Carlyle and Brighton Park, two investment firms. Financial terms were not disclosed.